Insomnia

Suicide risk is higher at night than any other time of day, according to a study published in Journal of Clinical Psychiatry. Researchers found no significant variation in this risk by method, month or demographic characteristics.

Two studies presented at the American Heart Association Epidemiology, Prevention, Lifestyle and Cardiometabolic Health Scientific Sessions demonstrated that optimal sleep patterns may reduce CVD risk and weight.

The American Academy of Neurology published a clinical practice guideline to address sleep disturbances in children and adolescents with autism spectrum disorder, or ASD, which included a recommendation that they be offered melatonin if other strategies are not helpful.

Vibratory and auditory stimulation may alter functional connectivity in the brain and improve sleep for patients with insomnia, according to results of a functional MRI study published in Sleep Disorders.

Patients with chronic pain and insomnia who frequently used medicinal cannabis to relieve those symptoms said the substance helped them maintain their sleep in the short term, researchers reported in BMJ Supportive & Palliative Care. However, over longer periods of time, these same patients appeared to develop a tolerance to the drug’s sleep-inducing properties.

Digital cognitive behavioral therapy was effective, scalable, safe and acceptable for improving insomnia symptoms among pregnant women, according to results of a randomized clinical trial published in JAMA Psychiatry.

No sleep for one night increased levels of the Alzheimer’s disease biomarker tau among young, healthy men, according to results of a two-condition crossover study published in Neurology.

Healio and Cardiology Today have compiled a list of the most-popular news on heart disease prevention published in 2019.

Patients with delirium may benefit from taking ramelteon or Belsomra, according to results of a prospective observational study published in Journal of Clinical Psychiatry.

The FDA approved Dayvigo 5 mg and 10 mg to treat adults with insomnia, according to a press release from the manufacturer.